Meet Brad Hively, our new Interim CEO and permanent member of the Board of Directors at Unio. With a passion for transforming healthcare, Brad brings a wealth of experience and a personal connection to the field of Gastroenterology. His decision to join Unio stems from the remarkable foundation Unio has built, and the opportunity to enhance patient experiences in Urology, GI, and Radiation Oncology. Brad's commitment to making healthcare more accessible, affordable, and sustainable aligns seamlessly with Unio's goals. Having successfully led three other physician practices; including most recently The Oncology Institute (NASDAQ: TOI); Brad emphasizes the importance of building a stellar team, fostering leadership, and executing with precision. His immediate priorities include team building, leadership development, and meticulous execution to leverage Unio's scale and enhance patient care. Welcome, Brad! #UnioHealthPartners #NewCEO #Healthcare #GenesisHealthcarePartners
Great to be here!
Brad, your personal brand of intelligent strategic thought coupled with your charismatic leadership style will serve this Company well.
Good luck, wishing you the best
Congrats Brad Hively. They are so lucky to have you.
They are lucky to have you Brad Hively
Congrats
Congratulations Brad! It was wonderful working under your leadership at TOI…best wishes in your new role!!!
Nice going, Brad 👍
Congrats, Brad Hively! Unio Health Partners is lucky to have you!
Professor at Stanford | Bestselling Author | Innovation | Venture Capital & Private Equity
9moBrad Hively congratulations! Great to see my students making more and bigger impact!